KSC Equity Snapshot
019170 Weekly Equity Report
Shinpoong Pharmaceutical Co.,Ltd
What the company does
Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; and drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; prescription drugs; wound dressings; health functional food; and over the counter products. In addition, the company engages in business management and exports its products to approximately 50 countries. The company was founded in 1962 and is …
What the weekly tape is saying
019170 closed the latest completed week at 9,070 KRW. The 4-week return is -16.7% and the 12-week return is -17.5%. Trend Signal is inactive, Market Dynamics is -0.50. Setup signature: Risk-first tape with a 7/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 12,173 KRW
- Vs Trend Line
- -25.5%
- Fair Value
- 12,513 KRW
- Vs Fair Value
- -27.5%
- 52W High
- 20,500 KRW
- 52W Low
- 7,900 KRW
- Drawdown
- -55.8%
- Range Position
- 9.3%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 29
- 52W Active Breadth
- 55.8%
- Sector Scope
- KR Healthcare
- Sector Rank
- 36 of 63
- Sector Percentile
- 43.5%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
KR Healthcare
- Tracked Peers
- 63
- 4W Rank
- 50 of 63
- Avg 1W
- -1.0%
- Avg 4W
- -12.7%
- Trend Breadth
- 1.6%
- Positive MD
- 6.3%
KR Drug Manufacturers - Specialty & Generic
- Tracked Peers
- 44
- 4W Rank
- 34 of 44
- Avg 1W
- -1.3%
- Avg 4W
- -12.9%
- Trend Breadth
- 2.3%
- Positive RS
- 0.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.50
- 4W MD Change
- -3543.3%
- Relative Strength
- -62.82
- 4W RS Change
- -14.7%
- Expectation
- Negative
- Probability
- 36.88%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 403.4K
- 13W Average
- 1.6M
- 52W Average
- 2.0M
- Vs 13W
- 0.3x
- Vs 52W
- 0.2x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 11.4%
- 52W Volatility
- 9.9%
- Upside Weeks
- 20
- Downside Weeks
- 31
- Downside Breadth
- 59.6%
- Avg Gain / Loss
- 7.4% / -4.5%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- KSC
- Country
- KR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- KRW
- Market Cap
- 499.8B
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 9,070 KRW | -0.7% | 12,173 KRW | 12,513 KRW | -0.50 | -62.82 | 403.4K | Off |
| 5 Jun 2026 | 9,130 KRW | -9.2% | 12,359 KRW | 12,561 KRW | -0.28 | -63.32 | 585.0K | Off |
| 29 May 2026 | 10,060 KRW | -8.2% | 12,519 KRW | 12,613 KRW | -0.11 | -61.75 | 827.1K | Off |
| 22 May 2026 | 10,960 KRW | 0.6% | 12,635 KRW | 12,658 KRW | -0.02 | -55.87 | 1.4M | Off |
| 15 May 2026 | 10,890 KRW | -5.4% | 12,726 KRW | 12,698 KRW | 0.01 | -54.77 | 3.1M | Off |
| 8 May 2026 | 11,510 KRW | -1.5% | 12,790 KRW | 12,737 KRW | 0.12 | -52.62 | 1.2M | Off |
| 1 May 2026 | 11,690 KRW | 1.0% | 12,829 KRW | 12,774 KRW | -0.28 | -45.76 | 802.6K | Off |
| 24 Apr 2026 | 11,570 KRW | -17.9% | 12,882 KRW | 12,816 KRW | -0.67 | -45.67 | 4.4M | Off |
| 17 Apr 2026 | 14,090 KRW | 33.7% | 12,933 KRW | 12,858 KRW | -1.09 | -31.31 | 6.8M | Off |
| 10 Apr 2026 | 10,540 KRW | 2.1% | 12,906 KRW | 12,887 KRW | -1.63 | -45.94 | 292.7K | Off |
| 3 Apr 2026 | 10,320 KRW | -6.4% | 12,987 KRW | 12,957 KRW | -1.65 | -42.71 | 375.0K | Off |
| 27 Mar 2026 | 11,030 KRW | 0.3% | 13,060 KRW | 13,011 KRW | -1.61 | -39.82 | 416.4K | Off |
| 20 Mar 2026 | 11,000 KRW | 0.0% | 13,103 KRW | 13,056 KRW | -1.53 | -43.84 | 290.0K | Off |
| 13 Mar 2026 | 11,000 KRW | -0.3% | 13,161 KRW | 13,099 KRW | -1.49 | -41.20 | 392.9K | Off |